Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.84
0.00 (-0.06%)
May 29, 2026, 12:31 PM EDT - Market open

Arvinas Revenue

Arvinas had revenue of $15.60M in the quarter ending March 31, 2026, a decrease of -91.74%. This brings the company's revenue in the last twelve months to $89.40M, down -79.06% year-over-year. In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%.

Revenue (ttm)
$89.40M
Revenue Growth
-79.06%
P/S Ratio
6.24
Revenue / Employee
$363,415
Employees
246
Market Cap
570.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 201814.32M6.75M89.00%
Dec 31, 20177.58M909.86K13.64%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE180.25M
Ginkgo Bioworks Holdings151.40M
Prime Medicine4.03M
ProKidney889.00K
Altimmune36.00K
Revenue Rankings